Hiroshi Ishimoto

3.4k total citations
163 papers, 2.4k citations indexed

About

Hiroshi Ishimoto is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Hiroshi Ishimoto has authored 163 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 47 papers in Epidemiology and 30 papers in Physiology. Recurrent topics in Hiroshi Ishimoto's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (58 papers), Pneumonia and Respiratory Infections (23 papers) and Medical Imaging and Pathology Studies (17 papers). Hiroshi Ishimoto is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (58 papers), Pneumonia and Respiratory Infections (23 papers) and Medical Imaging and Pathology Studies (17 papers). Hiroshi Ishimoto collaborates with scholars based in Japan, United States and Australia. Hiroshi Ishimoto's co-authors include Hiroshi Mukae, Kazuhiro Yatera, Noriho Sakamoto, Toshinori Kawanami, Kei Yamasaki, Shigeru Kohno, Shingo Noguchi, Yuji Ishimatsu, Tomoyuki Kakugawa and Takashi Kido and has published in prestigious journals such as Cell, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Hiroshi Ishimoto

150 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Ishimoto Japan 27 1.0k 796 399 318 291 163 2.4k
Anna‐Maija Teppo Finland 24 404 0.4× 463 0.6× 381 1.0× 226 0.7× 150 0.5× 57 2.4k
Burkhard Kreft Germany 27 421 0.4× 582 0.7× 450 1.1× 102 0.3× 150 0.5× 144 2.9k
Dimitri Poddighe Kazakhstan 27 310 0.3× 447 0.6× 202 0.5× 335 1.1× 209 0.7× 118 1.8k
Timo Jahnukainen Finland 28 699 0.7× 370 0.5× 494 1.2× 92 0.3× 204 0.7× 123 2.6k
Carolina Scagnolari Italy 32 658 0.6× 1.6k 2.0× 523 1.3× 174 0.5× 143 0.5× 169 3.3k
Naoto Keicho Japan 34 801 0.8× 854 1.1× 500 1.3× 243 0.8× 76 0.3× 121 2.8k
Richard E. Sobonya United States 24 1.3k 1.3× 556 0.7× 174 0.4× 495 1.6× 135 0.5× 92 2.3k
Klaus Dalhoff Germany 37 1.1k 1.1× 1.5k 1.9× 608 1.5× 656 2.1× 142 0.5× 141 4.2k
Haruyuki Ishii Japan 24 685 0.7× 634 0.8× 140 0.4× 234 0.7× 80 0.3× 123 1.6k
E Y United States 26 598 0.6× 496 0.6× 434 1.1× 671 2.1× 145 0.5× 39 2.8k

Countries citing papers authored by Hiroshi Ishimoto

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Ishimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Ishimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Ishimoto more than expected).

Fields of papers citing papers by Hiroshi Ishimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Ishimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Ishimoto. The network helps show where Hiroshi Ishimoto may publish in the future.

Co-authorship network of co-authors of Hiroshi Ishimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Ishimoto. A scholar is included among the top collaborators of Hiroshi Ishimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Ishimoto. Hiroshi Ishimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sakamoto, Noriho, Takashi Kido, Hiroshi Ishimoto, et al.. (2025). Antifibrotic effects of IL-12-treated natural killer cells on collagen type I regulation in lung fibroblasts. Experimental Cell Research. 449(1). 114584–114584. 2 indexed citations
3.
Sakamoto, Noriho, Hideki Hayashi, Tsutomu Fukuda, et al.. (2025). Lamellarin D Acts as an Inhibitor of Type I Collagen Production. ChemMedChem. 20(9). e202401001–e202401001. 1 indexed citations
4.
Kido, Takashi, Noriho Sakamoto, Ritsuko Murakami, et al.. (2025). Primary ciliary dyskinesia in a Japanese woman caused by a novel RSPH4A variant. Respiratory Investigation. 63(4). 507–509.
5.
Iwanaga, Naoki, Yuya Ito, Tatsuro Hirayama, et al.. (2024). Neglected Pulmonary Infection Caused by Exophiala dermatitidis Misidentified as Rhodotorula spp.. Mycoses. 67(10). e13804–e13804. 1 indexed citations
6.
Ishimoto, Hiroshi, Noriho Sakamoto, Ritsuko Miyashita, et al.. (2024). Novel method of attaching a suction tube externally to a tracheal tube as an insertion route for a Fogarty catheter in cryobiopsy: Retrospective comparative study. Respiratory Investigation. 62(4). 732–737.
7.
Hanada, Masatoshi, Yuji Ishimatsu, Noriho Sakamoto, et al.. (2023). Urinary titin N-fragment as a predictor of decreased skeletal muscle mass in patients with interstitial lung diseases. Scientific Reports. 13(1). 9723–9723. 3 indexed citations
8.
9.
Ishimoto, Hiroshi, Noriho Sakamoto, Takashi Kido, et al.. (2023). Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature. BMC Pulmonary Medicine. 23(1). 289–289. 4 indexed citations
10.
Sakamoto, Noriho, Ritsuko Miyashita, Takashi Kido, et al.. (2023). Pulmonary Langerhans cell histiocytosis diagnosed using transbronchial lung cryobiopsy: A case report. Respiratory Medicine Case Reports. 46. 101928–101928.
11.
Sakamoto, Noriho, et al.. (2023). HSP47: A Therapeutic Target in Pulmonary Fibrosis. Biomedicines. 11(9). 2387–2387. 14 indexed citations
12.
13.
Sakamoto, Noriho, Atsuko Hara, Takashi Kido, et al.. (2022). Two Distinct Mechanisms Underlying γδ T Cell-Mediated Regulation of Collagen Type I in Lung Fibroblasts. Cells. 11(18). 2816–2816. 4 indexed citations
14.
Kido, Takashi, Noriho Sakamoto, Atsuko Hara, et al.. (2022). Novel SPEF2 Variant in a Japanese Patient with Primary Ciliary Dyskinesia: A Case Report and Literature Review. Journal of Clinical Medicine. 12(1). 317–317. 3 indexed citations
15.
Kido, Takashi, Keiji Muramatsu, Takuto Miyamura, et al.. (2021). Impact of Corticosteroid Administration within 7 Days of the Hospitalization for Influenza Pneumonia with Respiratory Failure: A Propensity Score Analysis Using a Nationwide Administrative Database. Journal of Clinical Medicine. 10(3). 494–494. 7 indexed citations
16.
Sakamoto, Noriho, Hiroshi Ishimoto, Masahiro Tahara, et al.. (2021). HLA-B54 is an independent risk factor for pneumonia in Japanese patients with interstitial lung disease: A multicenter retrospective cohort study. Respiratory Medicine. 188. 106612–106612. 1 indexed citations
17.
Miyamura, Takuto, Noriho Sakamoto, Kaori Ishida, et al.. (2020). Presence of heat shock protein 47-positive fibroblasts in cancer stroma is associated with increased risk of postoperative recurrence in patients with lung cancer. Respiratory Research. 21(1). 234–234. 9 indexed citations
18.
Fukui, Shoichi, Shimpei Morimoto, Kunihiro Ichinose, et al.. (2020). Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosis. Scientific Reports. 10(1). 9466–9466. 7 indexed citations
19.
Miyamura, Takuto, Noriho Sakamoto, Tomoyuki Kakugawa, et al.. (2019). Postoperative acute exacerbation of interstitial pneumonia in pulmonary and non-pulmonary surgery: a retrospective study. Respiratory Research. 20(1). 154–154. 7 indexed citations
20.
Sakamoto, Noriho, Hiroshi Ishimoto, Tomoyuki Kakugawa, et al.. (2018). Elevated α-defensin levels in plasma and bronchoalveolar lavage fluid from patients with myositis-associated interstitial lung disease. BMC Pulmonary Medicine. 18(1). 44–44. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna‐Maija Teppo Breakdown of academic impact, for papers by Burkhard Kreft Breakdown of academic impact, for papers by Dimitri Poddighe Breakdown of academic impact, for papers by Timo Jahnukainen Breakdown of academic impact, for papers by Carolina Scagnolari Breakdown of academic impact, for papers by Naoto Keicho Breakdown of academic impact, for papers by Richard E. Sobonya Breakdown of academic impact, for papers by Klaus Dalhoff Breakdown of academic impact, for papers by Haruyuki Ishii Breakdown of academic impact, for papers by E Y
Rankless by CCL
2026